BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27635171)

  • 1. Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings.
    Ulus S; Suleyman E; Ozcan UA; Karaarslan E
    Pol J Radiol; 2016; 81():407-14. PubMed ID: 27635171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-contrast-enhanced whole-body magnetic resonance imaging in the general population: the incidence of abnormal findings in patients 50 years old and younger compared to older subjects.
    Cieszanowski A; Maj E; Kulisiewicz P; Grudzinski IP; Jakoniuk-Glodala K; Chlipala-Nitek I; Kaczynski B; Rowinski O
    PLoS One; 2014; 9(9):e107840. PubMed ID: 25259581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body muscle magnetic resonance imaging in patients with muscle symptoms: incidental findings and outcomes.
    Claeys KG; Goosens V
    Eur J Neurol; 2021 Jan; 28(1):323-330. PubMed ID: 32892468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
    Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
    Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body MRI in generalized cystic lymphangiomatosis in the pediatric population: diagnosis, differential diagnoses, and follow-up.
    Herruela-Suffee C; Warin M; Castier-Amouyel M; Dallery F; Bonnaire B; Constans JM
    Skeletal Radiol; 2016 Feb; 45(2):177-85. PubMed ID: 26545884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.
    Schmidt GP; Schoenberg SO; Schmid R; Stahl R; Tiling R; Becker CR; Reiser MF; Baur-Melnyk A
    Eur Radiol; 2007 Apr; 17(4):939-49. PubMed ID: 16951929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.
    Engelhard K; Hollenbach HP; Wohlfart K; von Imhoff E; Fellner FA
    Eur Radiol; 2004 Jan; 14(1):99-105. PubMed ID: 12845463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
    Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
    Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body computed tomography: a new point of view in a hospital check-up unit? Our experience in 6516 patients.
    Millor M; Bartolomé P; Pons MJ; Bastarrika G; Beloqui Ó; Cano D; González I; Vivas I
    Radiol Med; 2019 Dec; 124(12):1199-1211. PubMed ID: 31407223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body MRI for primary evaluation of malignant disease in children.
    Krohmer S; Sorge I; Krausse A; Kluge R; Bierbach U; Marwede D; Kahn T; Hirsch W
    Eur J Radiol; 2010 Apr; 74(1):256-61. PubMed ID: 19278802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].
    Schmidt GP; Baur-Melnyk A; Tiling R; Hahn K; Reiser MF; Schoenberg SO
    Radiologe; 2004 Sep; 44(9):889-98. PubMed ID: 15349732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Whole-body MRI in children with langerhans cell histiocytosis for the evaluation of the skeletal system].
    Steinborn M; Wörtler K; Nathrath M; Schöniger M; Hahn H; Rummeny EJ
    Rofo; 2008 Jul; 180(7):646-53. PubMed ID: 18561067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
    Pfannenberg C; Schwenzer N
    Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
    Mosavi F; Laurell A; Ahlström H
    Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.